Ruiqi Wang

3.2k total citations · 1 hit paper
115 papers, 1.6k citations indexed

About

Ruiqi Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruiqi Wang has authored 115 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 17 papers in Cancer Research and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruiqi Wang's work include Allergic Rhinitis and Sensitization (11 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (9 papers). Ruiqi Wang is often cited by papers focused on Allergic Rhinitis and Sensitization (11 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (9 papers). Ruiqi Wang collaborates with scholars based in China, United States and United Kingdom. Ruiqi Wang's co-authors include He Chen, Huilian Hou, Mei Xue, Xiang Wang, Hongli An, Jingjing Pan, Wei Chen, Xiang An, Xu Li and Huan Pang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Ruiqi Wang

105 papers receiving 1.6k citations

Hit Papers

Cancer epigenetics: from laboratory studies and clinical ... 2024 2026 2025 2024 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruiqi Wang China 23 920 553 164 150 140 115 1.6k
Jinchang Wu China 20 876 1.0× 470 0.8× 274 1.7× 162 1.1× 83 0.6× 56 1.5k
Zhaoqi Li United States 15 847 0.9× 413 0.7× 169 1.0× 93 0.6× 188 1.3× 31 1.7k
Baolong Wang China 21 613 0.7× 387 0.7× 191 1.2× 87 0.6× 189 1.4× 66 1.3k
Xiaohong Peng China 21 602 0.7× 344 0.6× 234 1.4× 128 0.9× 210 1.5× 61 1.4k
Lijing Wang China 20 668 0.7× 299 0.5× 178 1.1× 126 0.8× 182 1.3× 66 1.2k
Can Chen China 21 552 0.6× 276 0.5× 172 1.0× 149 1.0× 192 1.4× 90 1.3k
Jiaoyuan Li China 22 1.0k 1.1× 558 1.0× 275 1.7× 136 0.9× 54 0.4× 70 1.6k
Xiaochun Wang China 24 730 0.8× 342 0.6× 411 2.5× 242 1.6× 168 1.2× 64 1.7k

Countries citing papers authored by Ruiqi Wang

Since Specialization
Citations

This map shows the geographic impact of Ruiqi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiqi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiqi Wang more than expected).

Fields of papers citing papers by Ruiqi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruiqi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiqi Wang. The network helps show where Ruiqi Wang may publish in the future.

Co-authorship network of co-authors of Ruiqi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruiqi Wang. A scholar is included among the top collaborators of Ruiqi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiqi Wang. Ruiqi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xuyan, Ying Pan, Ke Zhou, et al.. (2025). AMPK: An energy sensor for non-small cell lung cancer progression and treatment. Pharmacological Research. 212. 107592–107592. 4 indexed citations
2.
Li, H., Ruiqi Wang, Jing Hu, et al.. (2024). A new pepper allergen Zan b 1.01 of 2S albumins: Identification, cloning, characterization, and cross-reactivity. Asian Pacific Journal of Allergy and Immunology. 43(4). 819–827. 2 indexed citations
3.
Liang, Dandan, Yu Zhang, Yixi Wang, et al.. (2024). Differences in the efficiency and mechanisms of different iron-based materials driving synchronous nitrogen and phosphorus removal. Environmental Research. 268. 120706–120706. 2 indexed citations
6.
Hu, Jing, Ruiqi Wang, Feng Chen, et al.. (2024). Identification, Characterization, Cloning, and Cross-Reactivity of Zan b 2, a Novel Pepper Allergen of 11S Legumin. Journal of Agricultural and Food Chemistry. 72(14). 8189–8199. 1 indexed citations
7.
Li, Jing, Ruiqi Wang, He Chen, et al.. (2023). Propofol Pretreatment Inhibits Liver Damage in Mice with Hepatic Ischemia/Reperfusion Injury and Protects Human Hepatocyte in Hypoxia/Reoxygenation. The Turkish Journal of Gastroenterology. 34(11). 1171–1179.
8.
Zhang, Yating, Nana Zhang, Gang Lin, et al.. (2023). A carbon catalyst doped with Co and N derived from the metal-organic framework hybrid (ZIF-8@ZIF-67) for efficient oxygen reduction reaction. Carbon. 206. 436–436. 1 indexed citations
9.
Wang, Linfang, Shuhua Li, Honglei Wang, et al.. (2023). Cyclin-G-associated kinase GAK/dAux regulates autophagy initiation via ULK1/Atg1 in glia. Proceedings of the National Academy of Sciences. 120(29). e2301002120–e2301002120. 8 indexed citations
10.
Wang, Bo, Zheyong Liang, Tan Tan, et al.. (2023). CRB3 navigates Rab11 trafficking vesicles to promote γTuRC assembly during ciliogenesis. eLife. 12. 2 indexed citations
11.
Wang, Ruiqi, et al.. (2023). Identifying key factors in cell fate decisions by machine learning interpretable strategies. Journal of Biological Physics. 49(4). 443–462. 2 indexed citations
12.
Wang, Bo, Zheyong Liang, Tan Tan, et al.. (2023). CRB3 navigates Rab11 trafficking vesicles to promote γTuRC assembly during ciliogenesis. eLife. 12. 1 indexed citations
13.
Tang, Rui, Yuxi Liu, Ruiqi Wang, et al.. (2022). Diagnostic accuracy and safety of Dermatophagoides pteronyssinus extracts used for skin prick test. Chinese Medical Journal. 135(21). 2563–2569. 1 indexed citations
14.
Wang, Ruiqi, et al.. (2022). Regulation of 3D Organization and Its Role in Cancer Biology. Frontiers in Cell and Developmental Biology. 10. 879465–879465. 8 indexed citations
15.
Wang, Bo, Lu Yang, Miao Zhang, et al.. (2022). FMNL2 suppresses cell migration and invasion of breast cancer: a reduction of cytoplasmic p27 via RhoA/LIMK/Cofilin pathway. Cell Death Discovery. 8(1). 155–155. 5 indexed citations
16.
Cui, Wei, et al.. (2021). Predictive Value of A Novel Lncrna LINC02518 in Evaluating the Prognosis of Patients with Hepatocellular Carcinoma. Biomarkers in Medicine. 15(14). 1277–1288. 4 indexed citations
17.
Yan, Yuxin, Ruiqi Wang, Xinyun Wu, et al.. (2021). The COVID-19 Vaccines: Recent Development, Challenges and Prospects. Vaccines. 9(4). 349–349. 59 indexed citations
18.
Liu, Li‐Ting, et al.. (2020). Traditional Chinese medicine for myasthenia gravis. Medicine. 99(29). e21294–e21294. 5 indexed citations
19.
Wang, Ruiqi, Chongjian Chen, Yu Jing, et al.. (2020). Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next‐generation sequencing technique. Cancer Medicine. 9(22). 8457–8467. 37 indexed citations
20.
Wang, Xuemei, Aiping Liu, Maolin Du, et al.. (2019). Diet quality is associated with reduced risk of hypertension among Inner Mongolia adults in northern China. Public Health Nutrition. 23(9). 1543–1554. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026